David Gortler
| David Gortler | |
 | |
| Basic facts | |
| Organization: | Heritage Foundation |
| Role: | Fellow in the Ethics and Public Policy Center’s HHS Accountability Project |
| Location: | Washington, D.C. |
| Expertise: | FDA Expert, Biotechnology, Pharmacology, Healthcare Policy and Drug Epidemiology |
| Affiliation: | Nonpartisan |
| Prior Experience | |
| Ted Cruz 2016 presidential campaign | |
David Gortler is a pharmacologist and pharmacist currently serving as a Senior Fellow in Health Policy and Regulation at the Heritage Foundation. Gortler was previously a member of the senior executive leadership team of the Food and Drug Administration (FDA). He also served as the FDA and healthcare policy advisor in the Ted Cruz 2016 presidential campaign.[1][2] In 2021, Gortler was selected to testify to the Committee on Oversight and Accountability Select Committee on the Coronavirus Pandemic.[3] Gortler describes his ideological affiliation as conservative, and outside of his scientific articles he has published policy and opinion articles across various platforms, including Forbes and The New American.[4][2]
Biography
Education
- University of Arizona (Doctor of Pharmacy/Clinical Pharmacology, 1998)
- Yale University (postdoctoral fellowship in investigational medicine pharmacology/molecular biology, 2002)
Career
Gortler was a didactic assistant professor of pharmacology at the Yale University School of Medicine, where he taught postgraduate-level clinical and basic science pharmacology, investigational medicine and FDA regulatory affairs to medical and Ph.D. students. He was involved in multiple interdisciplinary scientific and research collaborations and academic presentations to co-faculty. Prior to his faculty appointment at the Yale School of Medicine, he worked for Pfizer Inc. as an investigational medicine research scientist where he was in charge of designing and monitoring early-phase drug development studies and evaluating and reporting results.[5][6]
He also was involved in multiple interdisciplinary scientific and research collaborations and made multiple academic presentations to the faculty. He served as a faculty member of the Yale University Center for Bioethics, clinical trial ethics working group, and the research ethics writing group.[7]
Gortler served at the FDA under a total of three consecutive United States presidential administrations and served as the healthcare and FDA regulatory affairs and FDA policy advisor to both a United States president and presidential candidate Ted Cruz.[8] Gortler worked directly at the White House, updating and advising senior White House departmental directors, White House counsel, presidential special assistants, and presidential advisors on the latest, state-of-the-art recommendations to improve public health, FDA safety monitoring, assuring supply chain quality and integrity, and accelerate novel drug development.[9]
Gortler also served as a Fellow in the Ethics and Public Policy Center’s (EEPC) HHS Accountability Project, where his work focuses on FDA oversight and drug safety.[10]
Gortler has advocated for ending animal testing, enhancing public access to all FDA health documents and reports, and bringing pharmaceutical manufacturing and oversight back to the United States.[11][12][13]
Gortler was selected to testify to the Committee on Oversight and Accountability Select Committee on the Coronavirus Pandemic.[3] He has published a wide array of opinion pieces and research articles on topics like pharmaceutical oversight, public health transparency, and alternative drug safety testing methods.[7][9]
See also
External links
Footnotes
- ↑ Chain Drug Review, "David Gortler appointed by White House to a top post at FDA," August 24, 2020
- ↑ 2.0 2.1 Forbes, "Unforgivable Hypocrisy From FDA’s Career CDER Leadership," July 19, 2021
- ↑ 3.0 3.1 CONGRESSIONAL TESTIMONY, "Gorter Testimony COVID Select Committee" accessed November 15, 2024
- ↑ STAT, "7 ways to make the FDA great again, from a former agency official," December 6, 2016
- ↑ Congress.gov, "Dr. David Gortler - FDA Expert," accessed November 18, 2024
- ↑ Yale School of Medicine, "Yale’s Senior Advisor to the FDA Commissioner," accessed November 19, 2024
- ↑ 7.0 7.1 BBC, "Should organ donors be paid? The heavy toll of US kidney shortage," November 15, 2024
- ↑ Charlotte Lozier Institute, "David Gortler PharmD, FCCP," accessed November 18, 2024
- ↑ 9.0 9.1 Ethics & Public Policy Center, "David Gortler," accessed November 15, 2024
- ↑ Ethics and Public Policy Center, "David Gortler," accessed November 17, 2024
- ↑ The Heritage Foundation, "David Gortler," accessed November 18, 2024
- ↑ Forbes, "Moral Progress Denied By FDA Leadership: New ‘OOC’ Technology Could Have Allowed The FDA To Abandon Its Cruel Animal Testing Requirements," January 11, 2022
- ↑ Brownstone Institute, "FDA Knows That China and India Drug Quality Is Poor, But Independently Collects and Tests Only about 0.001%," November 6, 2024
